One dose of LSD provides weeks of anxiety relief, study finds
UC expert comments on new study to USA Today
The University of Cincinnati's Jeffrey Strawn was featured in a USA Today article commenting on a new study that found a pharmaceutical version of the psychedelic LSD might help alleviate anxiety symptoms for up to three months.
Study results were published Sept. 4 in the journal JAMA. The Phase 2, randomized clinical trial evaluated MM120, a pharmaceutical version of LSD, or lysergide D-tartrate, in 198 adults who had generalized anxiety disorder. After 12 weeks, anxiety symptoms improved in 65% of adults who took a single, 100-mg dose of the drug compared to 30.8% who took a placebo.
The study reported a "remission" rate of 47.5% among adults 12 weeks after taking a single dose compared to 20% who took a placebo. More than nine in 10 people on the 100-mg dose experience hallucinations, with other common side effects including nausea and headaches.
Strawn was not involved in the study, but oversees a clinical trial site for one of MM120's current Phase 3 studies. He said the study is "really important," as anxiety treatments have "really not significantly changed in decades."
"This is a disorder where often we are frustrated as clinicians marching through multiple treatments that don't work or produce side effects," Strawn, MD, professor in the Department of Psychiatry and Behavioral Neuroscience in UC’s College of Medicine and a UC Health child and adolescent psychiatrist, told USA Today. "Also, our patients are frustrated."
Featured photo at top of Dr. Strawn. Photo/Colleen Kelley/UC Marketing + Brand.
Related Stories
Can coal make a comeback?
February 24, 2026
Bloomberg Law speaks with Joseph Tomain, Dean Emeritus and Wilbert and Helen Ziegler Professor of Law at UC, about the federal government's push to promote use of coal plants for energy generation.
UC alum aims for summer Olympic debut
February 23, 2026
With the 2026 Winter Olympic Games coming to a close, attention now turns to the summer games coming up in Los Angeles in 2028. Beach sprint rowing is a relatively new sport that is surging in popularity due to its inclusion in the 2028 Los Angeles Olympic Games. Spectrum News 1 spoke with Lindner College of Business alum and most-decorated beach sprint rower of all time, Christopher Bak, on his Olympic-sized goals.
CCM singers advance to Metropolitan Opera Laffont Competition semifinals
February 23, 2026
Three UC College-Conservatory of Music alumni and one current student are semifinalists in the 2026 Metropolitan Opera Eric and Dominique Laffont Competition. One of the most prestigious singing competitions in the world, the Laffont Competition's national semifinals take place on Sunday, March 15, 2026.